Adherence to National Guidelines on Cervical Screening: A Population-Based Evaluation From a Statewide Registry

Abstract In 2012, national recommendations for cervical cancer screening of women aged 30-64 years were quinquennial human papillomavirus and cytology cotesting or triennial cytology. Data from a statewide surveillance program in New Mexico demonstrated 65.2% (95% confidence interval [95% CI] = 64.6...

Full description

Saved in:
Bibliographic Details
Published in:JNCI : Journal of the National Cancer Institute 2021-08, Vol.114 (4), p.626-630
Main Authors: Castle, Philip E, Kinney, Walter K, Chen, Lu, Kim, Jane J, Jenison, Steven, Rossi, Giovanna, Kang, Huining, Cuzick, Jack, Wheeler, Cosette M
Format: Article
Language:English
Subjects:
Brief Communications
Cancer
Cancer screening
Cellular biology
Cervical cancer
Cervix
Confidence intervals
Cytology
Human papillomavirus
Medical screening
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract In 2012, national recommendations for cervical cancer screening of women aged 30-64 years were quinquennial human papillomavirus and cytology cotesting or triennial cytology. Data from a statewide surveillance program in New Mexico demonstrated 65.2% (95% confidence interval [95% CI] = 64.6% to 65.7%) of women screened in 2019 had a negative cotest within the last 3 years. Percentages of women screened in 2013, 2016, and 2019 with a prior negative cotest more than 5 years and up to 7 years ago were 2.6% (95% CI = 2.2% to 2.9%), 2.1% (95% CI = 1.9% to 2.2%), and 6.5% (95% CI = 6.2% to 6.8%), respectively (2-sided Ptrend 
ISSN:0027-8874
1460-2105
DOI:10.1093/jnci/djab173